William T. Atchley

Researcher

UAMS

Also affiliated: University of North Carolina at Chapel Hill (2020); Pennsylvania State University (2014); North Carolina State University (2000); University of Michigan (2000); University of Arkansas Medical Center (2021–2022); Ann Arbor VA Medical Center (2000); Pulmonary and Critical Care Associates (2023)

Faculty Researcher

7 h-index 16 pubs 448 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

William T. Atchley's research focuses on pulmonary diseases, particularly chronic obstructive pulmonary disease (COPD) and its relationship with aging. His work also examines specific conditions like pulmonary hypertension in COPD and interstitial lung disease, investigating potential treatments such as inhaled nitric oxide. Atchley has also published on immune checkpoint inhibitor-related pneumonitis in lung cancer and the association of tocilizumab with fungal infections in critically ill COVID-19 patients.

His publications include studies on the pathophysiology and care of aging populations with COPD, as well as the interrelationships between aging and COPD. Atchley's scholarship metrics include an h-index of 7, with 16 total publications and 429 total citations. He has collaborated with several colleagues at the University of Arkansas for Medical Sciences, including Nikhil Meena, Rajani Jagana, Sarenthia M. Epps, and Barrett J. Burger, each with whom he shares three publications.

Metrics

h-index: 7
Publications: 16
Citations: 448

Selected Publications

Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care (2024)

Seminars in Respiratory and Critical Care Medicine 4 citations DOI OpenAlex
Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO) (2024)

DOI OpenAlex
Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions (2023)

Current Opinion in Pulmonary Medicine 7 citations DOI OpenAlex
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)

Life 9 citations DOI OpenAlex
Ageing and chronic obstructive pulmonary disease: interrelationships (2023)

Current Opinion in Pulmonary Medicine 7 citations DOI OpenAlex
Response (2022)

CHEST Journal DOI OpenAlex
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)

Research Square 5 citations DOI OpenAlex
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)

3 citations DOI OpenAlex
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer (2021)

CHEST Journal 179 citations DOI OpenAlex
Treatment with a Monoclonal Antibody against Methamphetamine and Amphetamine Reduces Maternal and Fetal Rat Brain Concentrations in Late Pregnancy (2014)

Drug Metabolism and Disposition 14 citations DOI OpenAlex